3651 results for «328»

Filter By

3651 results

From probe to patient: understanding echocardiography in structural heart disease

22 May 2025 – From EuroPCR 2025

Build foundational knowledge of echocardiography in structural heart disease. This session covers basic principles, diagnostic approaches correlating symptoms with valvular disease, and the vital role of echocardiography in post-procedural assessment and follow-up.

From probe to patient: understanding echocardiography in structural heart disease

Chronic coronary syndrome with low ejection fraction and left ventricle support

21 May 2025 – From EuroPCR 2025

This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.

Chronic coronary syndrome with low ejection fraction and left ventricle support

TAVI - Head-to-head comparative studies

22 May 2025 – From EuroPCR 2025

Compare head-to-head outcomes of various TAVI devices through real-world registries and meta-analyses. This session provides insights into performance differences between self-expanding and balloon-expandable valves to inform clinical decision-making.

TAVI - Head-to-head comparative studies

Right ventricule and tricuspid regurgitation: a linked faith

21 May 2025 – From EuroPCR 2025

Investigate the interconnected pathophysiology of right ventricular function and tricuspid regurgitation. This session reviews predictors of outcomes post-transcatheter tricuspid valve repair, the impact of disproportionate regurgitation, and changes in ventricular contraction patterns.

Right ventricule and tricuspid regurgitation: a linked faith

Pulmonary embolism - What should we do in the cathlab?

22 May 2025 – From EuroPCR 2025

Explore this session focused on pulmonary embolism management in the cathlab, highlighting when pharmacotherapy is insufficient and reviewing interventional options anticipated in 2025. Engage with real cases including polytrauma with acute respiratory failure and complex presentations like pre-syncope and scoliosis, accompanied by expert discussions and key...

Pulmonary embolism - What should we do in the cathlab?

Coronary dissection : when imaging makes the difference

21 May 2025 – From EuroPCR 2025

Explore the critical role of intracoronary imaging in diagnosing and managing coronary dissections and related complications. Through case studies, learn about bailout strategies and the domino effect of decisions during PCI in acute myocardial infarction.

Coronary dissection : when imaging makes the difference

Challenging scenarios in the pulmonary system - Part 1

21 May 2025 – From EuroPCR 2025

This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.

Challenging scenarios in the pulmonary system - Part 1

Best companion's cases on orbital atherectomy

22 May 2025 – From EuroPCR 2025

Dive into advanced cases demonstrating orbital atherectomy techniques for managing challenging calcified coronary lesions. This session includes innovative approaches such as 'sand and knock' calcium modification, orbital atherectomy in complex anatomies, and the use of optical coherence tomography to guide percutaneous treatment of calcified nodules.

Best companion's cases on orbital atherectomy

30 years of primary PCI – a tale of perseverance

16 May 2023

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

30 years of primary PCI – a tale of perseverance

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
Didn’t find what you were looking for?